FDA QMSR Explained: What Early-Stage Medical Device Companies Need to Know
The Quality Management System Regulation (QMSR), which amends 21 CFR Part 820, sets the quality-system standard for selling a medical device in the U.S. Here’s what emerging teams need to know. For emerging companies and early-stage development teams laser-focused on proving innovations, securing funding, and accelerating time-to-market, compliance can feel like a distant obligation. But […]
ISO 13485: What Early-Stage Medical Device Companies Need to Know
For early-stage medical device companies, quality management systems (QMS) often feel like a “later-stage problem.” In reality, they are a prerequisite for regulatory approval and commercialization. QMS requirements are upstream of design freeze, clinical trials, and regulatory submissions. Delaying implementation creates retroactive documentation risks that can derail timelines more than proactive compliance ever would. So, […]
Delivering a Faster Path to Market
Delivering a faster path to market: Staying ahead of the competition in 2025
Cell Therapy Manufacturing Services: Reducing Time to Market with Automation
As cell and gene therapies continue to revolutionize the healthcare landscape, manufacturers face a growing number of challenges in scaling production and bringing treatments to market efficiently. With patient-specific treatments and complex workflows, cell therapy manufacturing requires unparalleled precision, quality, and compliance. To overcome these hurdles, more companies are turning to cell therapy contract manufacturing […]
Webinar:Delivering a Faster Path to Market
Solving Quality Control Challenges in Cell Therapy Manufacturing
